Jennifer Callahan
Director of Finance/CFO at CINGULATE INC.
Net worth: 1 960 $ as of 30/04/2024
Profile
Jennifer L.
Callahan is currently working as a Controller at Cingulate Works, Inc. She also holds the position of Secretary, SVP, CFO & CAO at Cingulate, Inc. since 2017.
Ms. Callahan completed her undergraduate degree at Creighton University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
CINGULATE, INC.
0.06% | 15/03/2024 | 2,333 ( 0.06% ) | 1 960 $ | 30/04/2024 |
Jennifer Callahan active positions
Companies | Position | Start |
---|---|---|
CINGULATE INC. | Director of Finance/CFO | 29/01/2024 |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Comptroller/Controller/Auditor | - |
Training of Jennifer Callahan
Creighton University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CINGULATE INC. | Health Technology |
Private companies | 1 |
---|---|
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
- Stock Market
- Insiders
- Jennifer Callahan